Urologicheskie i andrologicheskie zabolevaniya pri sakharnom diabete


Cite item

Full Text

Abstract

References

  1. Ayta I. A., McKinlay J. B., Krane R. J. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. Br. J. Urol. Int. 1999; 84: 50-56.
  2. Craig A. One in ten. London: Impotence Association; 1998.
  3. Vinik A., Richardson D. Erectile dysfunction in diabetes. Diabet. Rev. 1998; 6 (1): 16-33.
  4. Brunner G. A., Pieber T. R., Schattenberg S. et al. Erectile dysfunction in patients with type I diabetes mellitus. Wien. Med. Wschr. 1995; 145 (21): 584-586.
  5. El-Rufaie O. E., Bener A., Abuzeid M. S., Ali T. A. Sexual dysfunction among type II diabetic men: a controlled study. J. Psychosom. Res. 1997; 43 (6): 605-612.
  6. Eardley I., Gale E. Diabetic impotence. In: Kirby R. S., Carson C. C., Webster G. D., eds. Impotence diagnosis and management of erectile dysfunction. Butterworth-Heinemann; 2001.
  7. Bancroft J., Gutierrez P. Erectile dysfunction in men wit and without diabetes mellitus: a comparative study. Diabet. Med. 1996; 13 (1): 84-89.
  8. Роживанов Р. В. Эректильная дисфункция у больных сахарным диабетом: скрининг, структура, прогностическое значение: Дис. ... канд. мед. наук. М.; 2005.
  9. Bacon C. G., Hu F. B., Giovanucci E. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabet. Care 2002; 25 (8): 1417.
  10. Коган М. И. (ред.). Нарушения половой функции у мужчин при сахарном диабете. М.; 2005.
  11. Fedele D., Bortolotti A., Coscelli C. et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. Int. J. Epidemiol. 2000; 29: 524-531.
  12. Jonler M., Moon T., Brannan W. et al. The effect of age, ethnicity and geographical location on impotence and quality of life. Br. J. Urol. 1995; 75: 651-655.
  13. De la Vega J. S., Amaya Gutierrez J., Alonso Flores J. J. et al. Erectile dysfunction in those under 40. Etiological and contributing factors. Arch. Esp. Urol. 2003; 56 (2): 161-164.
  14. Whitehead E. D., Klyde B. J. Diabetes-related impotence in the elderly. Clin. Geriatr. Med. 1990; 6: 771-795.
  15. Sullivan M. E., Thompson C. S., Dashwood M. R. et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res. 1999; 43 (3): 58-65.
  16. Siu S. C., Lo S. K., Wong K. W. et al. Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet. Med. 2001; 18 (9): 732-738.
  17. Romeo J. H., Seftel A. D., Madhun Z. T., Aron D. C. Sexual function in men with diabetes type 2: association with glycemic control. J. Urol. (Baltimore) 2000; 163 (3): 788-791.
  18. Naya Y., Mizutani Y., Ochiai A. et al. Preliminary report of association of chronic diseases and erectile dysfunction in middle-aged men in Japan. Urology 2003; 62 (3): 532-536.
  19. Shiri R., Koskimaki J., Hakama M. et al. Effect of chronic diseases on incidence of erectile dysfunction. Urology 2003; 62 (6): 1097-1102.
  20. Klein R., Klein B. E., Lee K. E. et al. Prevalence of selfreported erectile dysfunction in people with long-term IDDM. Diabet. Care 1996; 19 (2): 135-141.
  21. Tesfaye S., Stevens L. K., Stephenson J. M. et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.
  22. Фомкин Р. Г. Патогенез, диагностика и лечение эректильной дисфункции при сахарном диабете: Дис. ? канд. мед. наук. Ростов-н/Д.; 2001.
  23. Hakim L. S., Goldstein I. Diabetic sexual dysfunction. Endocrinol. Metab. Clin. N. Am. 1996; 25: 379-400.
  24. Harati Y. Diabetes and the nervous system. Endocrinol. Metab. Clin. Chron. Complicat. Diabet. 1996; 25 (2): 552-607.
  25. O'Hare J. A., Abuaisha F., Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir. J. Med. Sci. 1994; 163: 132-135.
  26. Vardi Y., Sprecher E., Kanter Y. et al. Polyneuropathy in impotence. Int. J. Impot. Res. 1996; 8 (2): 65-68.
  27. Vinik A. I., Maser R. E., Mitchell B. D., Freeman R. Diabetic autonomic neuropathy. Diabet. Care 2003; 26 (5): 1553-1579.
  28. Ziegler D. Clinical aspects, diagnosis and therapy of diabetic neuropathy. Ther. Umsch. 1996; 53 (12): 948-957.
  29. Rozhivanov R. V., Kalinchenko S. Yu. Neurological criteria of neurogenic erictile dysfunction diagnostics in patients with diabetes. In: Abstracts of 3-rd European congress of andrology, Munster, Germany, 11-14 Sept. 2004. Munster; 2004. 193.
  30. Benvenuti F., Boncinelli L., Vignoli G. C. Male sexual impotence in diabetes mellitus: vasculogenic versus neurogenic factors. Neurourol. and Urodyn. 1993; 12: 145-151.
  31. Kloner R. A., Speakman M. Erectile dysfunction and atherosclerosis. Curr. Atheroscler. Rep. 2002; 4 (5): 397-401.
  32. Nisen I. O., Alfthan O. S., Lindstrom B. L. et al. Cardiovascular reflexes in the neurological evaluation of impotence. Br. J. Urol. 1993; 71 (2): 199-203.
  33. Kayigil O., Atahan O., Metin A. Multifactorial evaluation of diabetic erectile dysfunction. Int. Urol. Nephrol. 1996; 28 (5): 717-721.
  34. Walczak M. K., Lokhandwala N., Hodge M. B., Guay A. T. Prevalence of cardiovascular risk factors in erectile dysfunction. J. Gend. Specif. Med. 2002; 5 (6): 19-24.
  35. Metro M. J., Broderick G. A. Diabetes and vascular impotence: does insulin dependence increase the relative severity? Int. J. Impot. Res. 1999; 11 (2): 87-89.
  36. Зубарев А. Р., Митькова М. Д., Корякин М. В., Митьков В. В. Ультразвуковая диагностика заболеваний наружных половых органов у мужчин. М.; 1999.
  37. Кротовский Г. С., Зудин А. М. Виагра - пять лет успеха. М.; 2003.
  38. Jevtich M. J., Kass M., Khawand N. Changes in the corpora cavernosa of impotent diabetics: comparing histological with clinical findings. J. Urol. (Paris) 1985; 91: 281-285.
  39. Seftel A. D., Vaziri N. D., Ni Z. et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997; 50 (6): 1016-1026.
  40. Hayashi K., Takamizawa K., Nakamura T. et al. Effects of elastase on the stiffness and elastic properties of arterial walls in cholesterol-fed rabbits. Atherosclerosis 1987; 66: 259-267.
  41. Bar-Moshe O., Vandendris M. Treatment of impotence due to perineal venous leakage by ligation of crura penis. J. Urol. (Baltimore) 1988; 139: 1217-1219.
  42. El-Sakka A. I. Penile axial rigidity and Doppler ultrasonography parameters in patients with erectile dysfunction: association with type 2 diabetes. Urology 2003; 62 (3): 525-531.
  43. Dhindsa S., Prabhakar S., Sethi M. et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J. Clin. Endocrinol. 2004; 89 (11): 5462-5468.
  44. Rossi P., Menchini Fabris F., Fiorini I. et al. Comparison between plasma concentrations of testosterone, nitric oxide an endothelin 1-2 in penile an brachial venous blood: preliminary results in men with psychogenic impotence. Biomed. and Pharmacother. 1998; 52 (7-8): 308-310.
  45. Schirar A., Chang C., Rousseau J. P. Localization of androgen receptor in nitric oxide synthase- an vasoactive intestinal peptide-containing neurons of the major pelvic ganglion innervating the rat penis. J. Neuroendocrinol. 1997; 9 (2): 141-150.
  46. Schiavi R. C., White D., Mandeli J., Schreiner-Engel P. Hormones nd nocturnal penile tumescence in healthy aging men. Arch. Sex. Behav. 1993; 22 (3): 207-215.
  47. Alexopoulou O., Jamart J., Maiter D. et al. Erectile dysfunction and lower androgenicity in type 1 diabetic patients. Diabet. Metab. 2001; 27 (3): 329-336.
  48. Baskin H. J. Endocrinologic evaluation of impotence. South. Med. J. 1989; 82 (40): 446-449.
  49. Cunningham M. J., Clifton D. K., Steiner R. A. Leptin's actions on the reproductive axis: perspectives an mechanisms. Biol. Reprod. 1999; 60: 216-222.
  50. Дедов И. И., Калинченко С. Ю. Возрастной андрогенный дефицит у мужчин. М.; 2006.
  51. Ермачек Е. А. Влияние пероральной сахароснижающей терапии на андрогенный статус и состояние половой функции у мужчин с сахарным диабетом типа 2: Дис. ? канд. мед. наук. М.; 2007.
  52. Veves A., Webster L., Chen T. F. et al. Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet. Med. 1995; 12 (1): 77-82.
  53. De Berardis G., Franciosi M., Belfiglio M. et al. The Quality of Care and Outcomes in Type 2 Diabetes (QuED) Study Group: Erectile dysfunction and quality of life in type 2 diabetic patients. Diabet. Care 2002; 25: 284-291.
  54. Rubin R. R., Peyrot M. Persistence of depressive symptoms in diabetic adults. Diabet. Care 1999; 22 (3): 448-452.
  55. Carton J. A., Maradona J. A., Nuno F. J. et al. Diabetes mellitus and bacteraemia: a comparative study between diabetic and nondiabetic patients. Eur. J. Med. 1992; 1: 281-287.
  56. Rendell M. S., Rajfer J., Wicker P. A., Smith M. D. For the Sildenafil Diabetes Study Group: Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. J. A. M. A. 1999; 281: 421-426.
  57. Willke R. J., Yen W., Parkerson G. R. et al. Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South Africa. Int. J. Impot. Res. 1998; 10: 239- 246.
  58. Enzlin P., Chantal M., Van Den Bruel A. et al. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabet. Care 2003; 26: 409-414.
  59. Кратохвил С. Психотерапия семейно-сексуальных дисгармоний. М.; 1991.
  60. Richardson D., Nalabanda A., Goldmeier D. Retarded ejaculation ? a review. Int. J. STD AIDS 2006; 17: 143-150.
  61. Nicolosi A., Glasser D. B., Brock G. et al. Diabetes and sexual function in older adults: results of an inernational survey. Br. J. Diabet. Vasc. Dis. 2002; 2: 336-339.
  62. Takahashi Y., Iwamoto Y. Sexual dysfunction in diabetes mellitus. Nippon Rinsho 1997; 55 (11): 2991-2995.
  63. Chartier-Kastler E., Averous M., Barrou B. et al. Diabetes and urination disorders. Progr. Urol. 2000; 10 (1): 14-23.
  64. Hill S. R., Fayyad A. M., Jones G. R. Diabetes mellitus and female lower urinary tract symptoms. Neurourol. and Urodyn. 2007.
  65. Hunter K. F., Moore K. N. Diabetes-associated bladder dysfunction in the older adult (CE). Geriatr. Nurs. 2003; 24 (3): 138- 145.
  66. Hampel C., Gillitzer R., Pahernik S. et al. Diabetes mellitus an bladder function. What should be considered? Urologe A 2003; 42 (12): 1556-1563.
  67. Yang Z., Dolber P. C., Fraser M. O. Diabetic urethropathy compounds the effects of diabetic cystopathy. J. Urol. (Baltimore) 2007; 178 (5): 2213-2219.
  68. Kebapc N., Yenilmez A., Efe B. et al. Bladder dysfunction in type 2 diabetic patients. Neurourol. and Urodyn. 2007; 26: 814-819.
  69. Esteghamati A., Rashidi A., Nikfallah A., Yousefizadeh A. The association between urodynamic findings and microvascular complications in patients with long-term type 2 diabetes but without voiding symptoms. Diabetes Res. Clin. Pract. 2007; 78 (1): 42- 50.
  70. Michel M. C., Mehlburger L., Schumacher H. et al. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J. Urol. (Baltimore) 2000; 163: 1725- 1729.
  71. Sarma A. V. Association between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling black and white men. Diabet. Care 2008; 31: 476-482.
  72. Dib P. T., Trigo-Rocha F., Gomes C. M., Srougi M. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms. Urol. Int. 2008; 80 (4): 378-382.
  73. Parsons J. K., Carter H. B., Partin A. W. et al. Metabolic factors associated with benign prostatic hyperplasia. J. Clin. Endocrinol. 2006; 91 (7): 2562-2568.
  74. Hammarsten J., Högstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press. 1999; 8 (1): 29-36.
  75. Дедов И. И., Шестакова М. В. Диабетическая нефропатия. М.; 2000.
  76. Geerlings S. E., Stolk R. P., Camps M. J. et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabet. Care 2000; 23: 744-749.
  77. Joshi N., Caputo G. M., Weitekamp M. R., Karchmer A. W. Infections in patients with diabetes mellitus. N. Engl. J. Med. 1999; 341: 1906-1912.
  78. Ludwig E. Urinary tract infections in diabetes mellitus. Orv. Hetil. 2008; 149 (13): 597-600.
  79. Geerlings S. E., Brouwer E. C., Van Kessel K. C. et al. Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest. 2000; 30: 995-1001.
  80. Geerlings S. E., Meiland R., van Lith E. C. et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabet. Care 2002; 25: 1405-1409.
  81. Geerlings S. E. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int. J. Antimicrob. Agents 2008; 31 (suppl. 1): 54-57.
  82. Mulvey M. A., Schilling J. D., Martinez J. J. et al. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA 2000; 97 (16): 8829-8835.
  83. Geerlings S. E., Stolk R. P., Camps M. J. L. et al. Risk factors for symptomatic urinary tract infection in women with diabetes mellitus. Diabet. Care 2000; 23 (12): 1737-1741.
  84. Hooton T. M., Scholes D., Stapleton A. E. et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N. Engl. J. Med. 2000; 343 (14): 992-997.
  85. Забиров К. И., Деревянко И. И., Марчук Н. В. Современные аспекты проблемы баланопостита. Consilium Medicum 2004; 6 (3).
  86. Hoepelman A. I., Meiland R., Geerlings S. E. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int. J. Antimicrob. Agents 2003; 22 (suppl. 2): 35-43.
  87. Dutta P., Bhansali A., Singh S. K. et al. Presentation and outcome of emphysematous renal tract disease in patients with diabetes mellitus. Urol. Int. 2007; 78 (1): 13-22.
  88. Guillausseau P. J., Farah R., Laloi-Michelin M. et al. Urinary tract infections and diabetes mellitus. Rev. Prat. 2003; 53 (16): 1790-1796.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies